Acute Kidney Injury in Patients Receiving Anti-Tuberculosis Treatment

Madiha Mehmood; Muhammad Anees

doi:10.53778/pjkd92302

Acute Kidney Injury in Patients Receiving Anti-Tuberculosis Treatment

Authors

Madiha Mehmood Department of Nephrology, King Edward Medical Universiy, Lahore, Pakistan
Dr Muhammad Anees Department of Nephrology, King Edward Medical Universiy, Lahore, Pakistan

DOI:

https://doi.org/10.53778/pjkd92302

Keywords:

acute kidney injury, anti tuberculous treatment, ATT, Rifampicin, Isoniazid, AKI

Abstract

Although life-saving, anti-tuberculosis therapy (ATT) carries the risk of acute kidney injury (AKI), potentially complicating its management.

Methods: 102 subjects starting on ATT were followed for 2 months. Presence of AKI was documented with monitoring of kidney functions.

Results:

AKI was observed among 14.7% patients, predominantly affecting middle-aged males.

Conclusion:

Early recognition of AKI by monitoring for kidney function is crucial for reducing the risk of long-term sequelae of kidney failure among patients taking ATT.

Downloads

Published

2025-06-30

How to Cite

Mehmood, M., & Anees, M. (2025). Acute Kidney Injury in Patients Receiving Anti-Tuberculosis Treatment. Pakistan Journal of Kidney Diseases, 9(2), 16–19. https://doi.org/10.53778/pjkd92302